Alliance Manager

Syndax Pharmaceuticals is looking for an Alliance Manager

At Syndax, we are determined to realize a future in which people with cancer live longer and better than ever before. Syndax Pharmaceuticals is a commercial stage biopharmaceutical company developing an innovative pipeline of cancer therapies.

The Role:

The Alliance Manager will report to the Chief Strategy Officer and will be responsible for managing, coordinating, and optimizing the alliance between Syndax and our strategic partners, contribute to the definition and development of the Alliance management function at Syndax, and help to evaluate and advise on key aspects of potential future alliances or partnered programs.

Key Responsibilities:

• Leading and/or guiding the governance of strategic partnerships, including managing governance committees, identifying key issues, driving solutions ensuring the interests of Syndax are well represented within the partnership, and facilitating decision-making.
• Work directly with the partner company to ensure the Syndax teams are aware of and involved in decision making across functional teams and budget discussions as defined by the partnership agreement.
• Monitor implementation of and adherence to agreed-upon research, development and commercialization plans; take appropriate action to ensure execution.
• Issues management- address hot topic issues that require immediate attention while working to minimize potential crisis situations
• Perform regular alliance audits and health checks
• Liaise with legal, finance, R&D, Commercial and other functions to ensure that key contract milestones, financial transactions, progress reports, etc. are handled appropriately and provide information/updates as needed.
• Maintain appropriate boundaries between internal project teams and partner-focused discussions, where required.
• Lead the internal Syndax team to ensure clear positions on key topics that will come up for alliance alignment.
• Conduct regular reviews/meetings with senior management and other functions as appropriate to communicate key issues, milestones, etc. and gather feedback.
• Participate in review of new partner contract negotiations as appropriate and provide input into partnership execution terms of the contract, in particular governance structures and processes.
  
  

Desired Experience/Education and Personal Attributes:

• Graduate level degree preferred; Bachelor’s degree required.
• 5 years’ experience in life sciences Alliance Management or related function.
• >2 years’ experience working as an alliance manager or in an alliance structure.
• Strong leadership, cross functional experience and self-direction.
• Excellent interpersonal skills with ability to lead, interact with, focus, negotiate, influence and resolve conflict.
• Demonstrated ability to identify, prioritize and resolve key project and partnership issues.
• Demonstrated ability to interact with and to present to senior leadership.
• Demonstrated attention to detail and excellence in project management and effectively managing multiple projects/priorities.
• Must be able to handle ambiguity well and operate in a matrix team.
• Excellent communication skills with an ability to efficiently and productively communicate both orally and in writing.
• Preferred: Knowledge and experience in oncology, immunology/inflammation, and/or cell therapy.
  
  

Location: Syndax’s corporate office is in New York, NY.

Syndax offers a total compensation and rewards package that is among the most competitive in the industry. Base pay is just one element of our package and is determined within a range based on several factors including market data, experience, qualifications, demonstrated skills, relevant education or training, travel requirements and internal equity. Our overall package also includes an equity offering, annual target bonuses, and an outstanding benefits program. The anticipated annualized salary range for this role is $235,000-250,000.

About Syndax:

Syndax Pharmaceuticals is a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies. Highlights of the Company's pipeline include Revuforj® (revumenib), an FDA-approved menin inhibitor, and Niktimvo™ (axatilimab-csfr), an FDA-approved monoclonal antibody that blocks the colony stimulating factor 1 (CSF-1) receptor. Fueled by our commitment to reimagining cancer care, Syndax is working to unlock the full potential of its pipeline and is conducting several clinical trials across the continuum of treatment. For more information, please visit www.syndax.com/ or follow the Company on X (formerly Twitter) and LinkedIn.

Syndax Pharmaceuticals is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.